文献速递肿瘤 PET/CT

18F-氟羧酸PET在前列腺癌切除床检出低PSA 0.3 ng/mL的早期肿瘤复发而18F-PSMA PET阴性

18 F-Fluciclovine PET Detected Early Tumor Recurrence in Prostatectomy Bed With Low PSA of 0.3 ng/mL But Negative on 18 F-PSMA PET Scan.
PubMed 文献 · Clin Nucl Med · 2022-08-04

一例58岁转移性前列腺癌患者经前列腺切除术、骨转移放疗及雄激素剥夺联合阿比特龙治疗后PSA降至0.1 ng/mL。随访PSA 0.3 ng/mL时,18F-氟羧酸PET显示左前列腺切除床局灶性示踪剂摄取,而18F-DCFPyL PET/CT阴性,MRI显示典型复发特征。氟羧酸尿路活性极低有助于检出局部复发。

要点

  • 18F-氟羧酸PET在PSA 0.3 ng/mL时检出前列腺切除床局灶摄取,而18F-PSMA PET阴性。
  • 氟羧酸尿路活性极低有助于前列腺切除床局部复发的检出。
  • MRI显示该病灶具有典型复发特征。

核心结论

  • 18F-氟羧酸PET在前列腺切除床检出早期肿瘤复发,而18F-PSMA PET扫描阴性,氟羧酸尿路活性极低有助于局部复发检出。

研究设计与样本

  • 病例报告:一例58岁转移性前列腺癌患者,接受前列腺切除术、骨转移放疗及雄激素剥夺联合阿比特龙治疗。

主要发现

  • 治疗后PSA最低值为0.1 ng/mL;随访PSA 0.3 ng/mL时,18F-氟羧酸PET显示左前列腺切除床局灶性示踪剂摄取。
  • 该病灶在18F-DCFPyL PET/CT上为阴性,但MRI显示典型复发特征。
  • 氟羧酸尿路活性极低有助于检出前列腺切除床局部复发。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

A 58-year-old man with metastatic prostate cancer was treated with prostatectomy, radiation therapy to bone metastasis, and androgen deprivation therapy plus abiraterone. He had posttreatment nadir PSA of 0.1 ng/mL. A follow-up 18 F-fluciclovine PET performed with PSA of 0.3 ng/mL showed a focal tracer-avid lesion in the left prostatectomy bed. This lesion was negative on 18 F-DCFPyL PET/CT, but with typical MRI features for disease recurrence. Minimal urinary activity of fluciclovine helped detection of local disease recurrence in the prostatectomy bed.

来源:Clin Nucl Med,查看原文。版权归原作者所有。

引用

  1. Nguyen TT, Bhosale PR, Lu Y, et al. 18 F-Fluciclovine PET Detected Early Tumor Recurrence in Prostatectomy Bed With Low PSA of 0.3 ng/mL But Negative on 18 F-PSMA PET Scan. Clin Nucl Med. 2022. PMID: 35961367. doi:10.1097/RLU.0000000000004356

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。